-
Oberoi Realty
1,751.00 1,440.05(%) -
Canara Bank
106.35 78.58(%) -
SpiceJet
40.84 79.90(%) -
Lodha Developers
1,330.55 1,036.00(%) -
Havells India
1,549.05 1,360.05(%) -
ICICI Bank
1,489.95 1,482.00(%) -
One 97
1,090.00 1,063.00(%) -
Bombay Dyeing
190.85 256.25(%) -
Ola Electric
43.95 157.53(%) -
Dixon Technolog.
16,671.15 19,149.80(%) -
Anthem Bioscienc
765.00 752.50(%) -
Eternal Ltd
303.60 311.60(%) -
Paradeep Phosph.
205.60 193.15(%) -
Pidilite Inds.
2,900.75 2,620.15(%) -
Reliance Industr
1,426.90 1,551.00(%) -
I R F C
136.90 209.10(%) -
St Bk of India
825.00 895.30(%) -
Waaree Energies
3,199.00 3,740.75(%) -
Jayaswal Neco
43.10 55.34(%) -
Tata Motors
692.95 1,179.05(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Dr Lal Pathlabs Ltd Healthcare
- Indian Private
- BSE Code : 41261.0
- ISIN : INE600L01024
-
Today’s Low
2,947.50 -
Today’s High
3,019.80

-
Open
2,973.60 -
Perv Close
2,973.60 -
52W Low
2,293.55 -
52W High
3,653.95
Key Indicators
-
P/E(TTM)
50.45
-
Mar.Cap (₹Cr.)
25,166.16
-
Div & Yield %
0.80
-
Book Value(₹)
254.78
-
Debt-Equity Ratio
1.02
-
AGM Date
22-Jul-2025
-
EPS
59.55
-
P/E Ratio
50.45
Financials Ratios
-
Debt-Equity Ratio
0.19
-
Mar.Cap (₹Cr.)
25,166.16
-
RONW (%)
20.61
-
ROCE (%)
25.58
Score Board
-
Equity (₹ in Cr.)
83.78
-
BV (₹)
254.80
-
Sales( ₹ in Cr.)
2,351.62
-
NP (in Cr.)
498.85
-
NP Var(%)
30.0
-
Div%
240.0
-
CPS (₹)
75.60
-
EPS (₹)
59.50
-
Traded Value (₹ in Lakhs)
25,168.68
-
52 Week High
3,653.95
-
52 Week Low
2,293.55
-
Price BSE
3004.0
-
Price NSE
3,004.00
-
Market Capital( in Cr.)
25,168.68
-
P/C Ratio
39.80
-
P/E Ratio
50.40
-
Price Vs.BV
59.50
-
25-Jun-2025( 01:53)
Corporate News - Dr La... - <P><A href=javascript:AddCoCod...
-
25-Jun-2025( 01:53)
Corporate News - Dr La... - <P><A href=javascript:AddCoCod...
-
25-Apr-2025( 03:23)
Corporate News - Board... - Dr. Lal PathLabs announced tha...
-
25-Apr-2025( 03:23)
Corporate News - Dr. L... - Dr. Lal PathLabs announced tha...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 2,351.62 | 1,966.76 | 1,769.03 | 1,878.79 | 1,490.56 | 1,273.60 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 2,351.62 | 1,966.76 | 1,769.03 | 1,878.79 | 1,490.56 | 1,273.60 |
Other Income | 111.52 | 60.11 | 46.60 | 53.10 | 51.27 | 57.61 |
Stock Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Income | 2,463.14 | 2,026.87 | 1,815.63 | 1,931.89 | 1,541.83 | 1,331.21 |
EXPENDITURE : | ||||||
Raw Materials | 455.24 | 390.76 | 389.64 | 447.65 | 373.90 | 286.87 |
Power and Fuel Cost | 25.48 | 21.54 | 21.31 | 19.66 | 17.18 | 15.65 |
Employee Cost | 457.54 | 363.59 | 315.50 | 321.44 | 257.44 | 232.07 |
Other Manufacturing Expenses | 438.81 | 376.33 | 344.15 | 336.38 | 243.96 | 212.40 |
Selling and Administration Expenses | 261.40 | 209.38 | 196.57 | 196.04 | 152.52 | 161.60 |
Miscellaneous Expenses | 47.75 | 45.93 | 41.17 | 45.16 | 38.18 | 37.20 |
Employee Benefit Expenses | 457.54 | 363.59 | 315.50 | 321.44 | 257.44 | 232.07 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 1,686.21 | 1,407.52 | 1,308.33 | 1,366.32 | 1,083.18 | 945.79 |
Operating Profit | 776.93 | 619.35 | 507.30 | 565.57 | 458.65 | 385.42 |
Interest | 21.50 | 26.84 | 34.38 | 28.63 | 14.83 | 14.66 |
Gross Profit | 755.43 | 592.51 | 472.92 | 536.94 | 443.82 | 370.76 |
Depreciation | 134.15 | 76.54 | 82.09 | 75.94 | 69.78 | 68.01 |
Profit Before Tax | 621.28 | 515.97 | 390.83 | 461.00 | 374.04 | 302.75 |
Current Tax | 163.34 | 137.58 | 101.44 | 118.42 | 98.43 | 80.25 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -39.32 | -5.98 | -2.97 | -2.68 | -4.49 | -0.67 |
Reported Net Profit | 497.26 | 384.37 | 292.36 | 345.25 | 280.11 | 223.18 |
Extraordinary Items | -1.59 | 0.24 | 1.11 | 0.20 | -0.13 | 0.11 |
Adjusted Net Profit | 498.85 | 384.13 | 291.25 | 345.05 | 280.24 | 223.07 |
Adjustment below Net Profit | -3.90 | -0.27 | 1.94 | -1.32 | -0.71 | -6.72 |
P & L Balance brought forward | 1,528.75 | 1,378.66 | 1,183.79 | 955.56 | 773.56 | 704.92 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 199.91 | 199.48 | 99.43 | 115.71 | 99.11 | 147.82 |
P & L Balance carried down | 1,822.20 | 1,563.28 | 1,378.66 | 1,183.79 | 953.84 | 773.56 |
Dividend | 149.97 | 149.65 | 49.72 | 115.71 | 99.11 | 98.93 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 240.00 | 240.00 | 120.00 | 120.00 | 200.00 | 120.00 |
Dividend Per Share(Rs) | 24.00 | 24.00 | 12.00 | 12.00 | 20.00 | 12.00 |
Earnings Per Share-Unit Curr | 59.49 | 46.04 | 35.07 | 41.42 | 33.61 | 26.78 |
Earnings Per Share(Adj)-Unit Curr | 59.49 | 46.04 | 35.07 | 41.42 | 33.61 | 26.78 |
Book Value | 255.32 | 227.56 | 202.70 | 176.63 | 146.03 | 124.83 |
Book Value(Adj)-Unit Curr | 255.32 | 227.56 | 202.70 | 176.63 | 146.03 | 124.83 |